The diagnosis and misdiagnosis of tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 11, 2008, Pages 1226-1234

  Davies, Peter D O ^a   Pai, M ^b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CHEST INFECTION; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FIBEROPTIC BRONCHOSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LIFESTYLE; LUMBAR PUNCTURE; MILIARY TUBERCULOSIS; NIGHT SWEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RISK FACTOR; SERODIAGNOSIS; SPUTUM CYTODIAGNOSIS; STOMACH LAVAGE; TUBERCULOSIS; TUBERCULOUS MENINGITIS; UNITED KINGDOM; WEIGHT REDUCTION;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; SENSITIVITY AND SPECIFICITY; SEROTYPING; SPUTUM; TUBERCULOSIS;

EID: 56249149272     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Centers for Disease Control and Prevention. Tuberculosis. 1996 case definitions. http://www.cdc.gov/epo/dphsi/casedef/tuberculosis_current.htm Atlanta, GA, USA: CDC, 2006. Accessed November 2007.
2. Health Protection Agency. Annual report on tuberculosis cases reported in England, Wales and Northern Ireland in 2003. London, UK: HPA, 2007. http://www.hpa.org.uk/infections/topics_az/tb/pdf/2003_Annual_Report.pdf Accessed January 2008.
3. Health Protection Agency. Tuberculosis in the UK. London, UK: HPA, 2007. http://www.hpa.org.uk/publications/2007/TB/TB_annual_report.pdf Accessed December 2007.
4. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: Royal College of Physicians, 2006.
5. Health Protection Agency. Tuberculosis rates by place of birth and ethnic group, England, Wales and Northern Ireland, 2001-2006. London, UK: HPA, 2007. http://www.hpa.org.uk/infections/topics_az/tb/epidemiology/figures/figure15.htm Accessed January 2008.
6. Rieder H L, Cauthen G W, Comstock G W, Snider D E. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11: 79-98.
7. Spence D P S, Hotchkiss J, Williams C S D, Davies P D O. Tuberculosis and poverty. BMJ 1993; 307: 759-761.
8. Tocque K, Bellis M A, Beeching N, Sayed Q, Remmington T, Davies P D O. A case-control study of lifestyle risk factors associated with tuberculosis in the city of Liverpool, Northwest England. Eur Respir J 2001; 18: 959-964.
9. Davies P D O, Yew W W, Gangully D, et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans Roy Soc Trop Med Hyg 2006; 100: 291-298.
10. Brandli O. The clinical presentation of tuberculosis. Respiration 1998; 65: 97-105.
11. Davies P D O, Byfield S P, Nunn A J, et al. National survey of tuberculosis notifications in England and Wales 1978-9. Report from the Medical Research Council Tuberculosis and Chest Disease Unit. BMJ 1980; 281: 895-898.
12. Pai M, Flores L L, Pai N, Hubbard A, Riley L W, Colford J M Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003; 3: 633-643.
13. Davies P D O, Barnes P F, Gordon S B, eds. Clinical tuberculosis. 4th ed. London, UK: Hodder Arnold, 2008: 315-342.
14. Geng E, Kreiswirth B, Burzynski J, et al. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA 2005; 293: 2740-2745.
15. Ellis S M. The spectrum of tuberculosis and non-tuberculous mycobacterial infection. Eur Radiol 2004; 14 (Suppl 3): E34-42.
16. Hopewell P C, Pai M, Maher D, Uplekar M, Raviglione M C. International standards for tuberculosis care. Lancet Infect Dis 2006; 6: 710-725.
17. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR Recomm Rep 1994; 43 (RR-13): 1-132.
18. Jakubowiak W. TB manual, National Tuberculosis Programme guidelines. Warsaw, Poland: WHO, 2001.
19. Mathew P, Kuo Y H, Vazirani B, et al. Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation? J Clin Microbiol 2002; 40: 3482-3484.
20. Mase S R, Ramsay A, Ng V, et al. Yield of serial sputum specimen examination in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007; 11: 485-495.
21. Craft D W, Jones M C, Blanchet C N, et al. Value of examining three acid-fast bacillus sputum smears for removal of patients suspected of having tuberculosis from the 'airborne precautions' category. J Clin Microbiol 2000; 38: 4285-4287.
22. World Health Organization. Reduction of number of smears for the diagnosis of pulmonary tuberculosis. Geneva, Switzerland: WHO, 2007. http://www.who.int/tb/dots/laboratory/policy/en/index2.html Accessed January 2008.
23. Wu Z L, Wang A Q. Diagnostic yield of repeated smear microscopy examinations among patients suspected of pulmonary tuberculosis in Shandong province of China. Int J Tuberc Lung Dis 2000; 4: 1086-1087.
24. Steingart K R, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-581.
25. Steingart K R, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 664-674.
26. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children, 1999. Am J Respir Crit Care Med 2000; 161: 1376-1395.
27. Bergmann J S, Yuoh G, Fish G, et al. Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium tuberculosis direct test for rapid diagnosis of tuberculosis in prison inmates. J Clin Microbiol 1999; 37: 1419-1425.
28. Moore D A, Evans C A, Gilman R H, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550.
29. Cohen R A, Muzaffar S, Schwartz D, et al. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998; 157: 156-161.
30. Dalovisio J R, Montenegro-James S, Kemmerly S A, et al. Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clin Infect Dis 1996; 23: 1099-1106; discussion 1107-1108.
31. Chedore P, Jamieson F B. Routine use of the Gen-Probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory. Diagn Microbiol Infect Dis 1999; 35: 185-191.
32. Flores L L, Pai M, Colford J M Jr, Riley L W. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol 2005; 5: 55.
33. Pai M, Flores L L, Hubbard A, Riley L W, Colford J M Jr. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 2004; 4: 6.
34. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006; 61: 783-790.
35. Sarmiento O L, Weigle K A, Alexander J, Weber D J, Miller W C. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 2003; 41: 3233-3240.
36. Daley P, Thomas S, Pai M. Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis 2007; 11: 1166-1176.
37. Cook V J, Fitzgerald J M, Menzies D. Clinical interpretation of tests for latent tuberculosis infection. In: Davies PDO, Barnes P F, Gordon S B, eds. Clinical tuberculosis. 4th ed. London, UK: Hodder Arnold, 2008: 383-410.
38. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
39. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
40. Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44: 74-77.
41. Janssens J P, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J 2007; 30: 722-728.
42. Davies P D, Drobniewski F. The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur Respir J 2006; 28: 1-3.
43. Mazurek G H, Jereb J, Lobue P, Iademarco M F, Metchock B, Vernon A. Guidelines for using the quantiferon-TB gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
44. Jafari C, Ernst M, Diel R, et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006; 174: 1048-1054.
45. Losi M, Bossink A, Codecasa L, et al. Use of a t-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007; 30: 1173-1179.
46. Steingart K R, Henry M, Laal S, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis. Thorax 2007; 62: 911-918.
47. Steingart K R, Henry M, Laal S, et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 2007; 4: e202.
48. Steingart K R, Ramsay A, Pai M. Commercial serological tests for the diagnosis of tuberculosis: do they work? Future Microbiol 2007; 2: 355-359.
49. Perkins M D, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007; 196 (Suppl 1): S15-S27.
50. Silver C P, Steele S J. Mediastinal lymphatic gland tuberculosis in Asian and coloured immigrants. Lancet 1961; 1: 1254-1256.
51. Catano J C. Cerebral tuberculoma in images in clinical medicine. New Engl J Med 2007; 377: 21.
52. Wallgren A. The time table of tuberculosis. Tubercle 1948; 29: 245.
53. Davies P D O. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985; 66: 301-306.
54. Rubilar M, Sime P J, Moudgil H, Chilvers E R, Leitch A G. Time to extend 'the timetable of tuberculosis'? Respir Med 1994; 88: 481-482.
55. Corless J A, Stockton P A, Davies P D. Mycobacterial culture results of smear-positive patients with suspected pulmonary tuberculosis in Liverpool. Eur Respir J 2000; 16: 976-979.
56. Patiala J. Initial tuberculous pleuntis in the Finnish armed forces in 1939-45 with special reference to eventual postpleuritic tuberculosis. Copenhagen, Denmark: Enjar Munksgaard, 1955.
57. Davies P D O. Tuberculosis in the elderly in industrialised countries. Int J Tuberc Lung Dis 2007; 11: 1157-1159.